Roflumilast Cream 0.3%

roflumilast cream · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Roflumilast Cream 0.3%, covering 2025-05-16 to 2025-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study [Phase 3]